American Cancer Society Institutional Research Grant
The purpose of the American Cancer Society’s Institutional Research Grant (ACS-IRG) is to support the initiation of promising new cancer-related research projects by junior faculty members (Assistant Professors or their equivalents), so they can obtain preliminary results that will enable them to compete successfully for national research grants. Up to four awards are made annually. As part of the ACS Diversity, Equity, and Inclusion Strategy, special consideration is be given to underrepresented minority investigators.
Grantees
Metal Mixtures and Lung Cancer Incidence in Cigarette Smokers from the Multiethnic Cohort Study.
Shannon Sullivan, PhD, MPH, MS, Department of Laboratory Medicine and Pathology, Medical School
Targeting protein-protein interactions in resistant ER+ breast cancer.
Thu Truong, PhD, Department of Biochemistry, Molecular Biology and Biophysics, Medical School
Characterizing Health Care Contact Days Among Older Cancer Survivors
Arjun Gupta, MD, Division of Hematology, Oncology and Transplantation
Helen Parsons, PhD, MPH, Division of Health Policy and Management, School of Public Health
Functional proteomic insights into the mechanisms of HDAC6 inhibitor treatment sensitivity in high-grade serous ovarian cancer
Stefani Thomas, PhD, Department of Laboratory Medicine and Pathology, Medical School
VISTA CAR-T for treatment of Myelodysplastic syndrome
Jeremy Allred, MD, Division of Hematology, Oncology, and Transplantation, Medical School
Health Beliefs and Behaviors of Lung Cancer Screening in Chinese Americans
Fang Lei, PhD, MPH, MSN, School of Nursing
Feasibility of a Nature Based Intervention in Young Adult Cancer Survivors
Erica Timko Olson, PhD, RN, Clinical Assistant Professor, School of Nursing
Delineating the mechanisms of PKM2 mediated genetic and epigenetic regulation in CD8 T cells
Vivek Verma, PhD, Hormel Research Institute
Integrative genomic analyses to identify etiologic heterogeneity in pediatric ependymoma by molecular subtype
Lindsay Williams, PhD, MPH, Pediatrics, Medical School
RSPO2 as a vulnerability in therapy resistant metastatic prostate cancer
Justin Hwang, PhD, Division of Hematology, Oncology and Transplantation, Medical School
Defining the Role of Methyl Donor Availability in Hepatocellular Carcinoma Pathophysiology and the Underlying Metabolic Remodeling
Curtis Hughey, PhD, Division of Molecular Medicine, Medical School
Local and Systemic Effects of Irreversible Electroporation on Pancreas Cancer Associated Dendritic Cells
Jacob Ankeny, MD, Department of Surgery, Medical School
Exploring Sexual Health Needs of Women with Gynecologic Cancers
Abby Girard, PsyD, Family Medicine and Community Health, Medical School
Nic Rider, PhD, Family Medicine and Community Health, Medical School
Effects of myeloproliferative-neoplasm associated calreticulin mutations on the vascular endothelium
Joan Beckman, MD, PhD, Division of Hematology, Oncology and Transplantation, Medical School
Robert Hebbel, MD, PhD, Division of Hematology, Oncology and Transplantation, Medical School
Michael Linden, MD, PhD, Department of Laboratory Medicine and Pathology, Medical School
Veronika Bachanova, MD, PhD, Division of Hematology, Oncology and Transplantation, Medical School